Collierville man named as plaintiff in class action lawsuit against JUUL e-cigarettes

Local News

COLLIERVILLE, Tenn. ( – A Collierville man is named as a plaintiff in a class action lawsuit against JUUL e-cigarettes and tobacco companies Altria Group and Philip Morris USA.

The lawsuit, filed by a Mississippi law firm last week, contends the 25-year-old man is addicted to JUUL e-cigarettes, causing him harm – including the “exposure to significant toxic substances, nicotine addiction, and economic harm.”

The suit contends JUUL’s “chemically manipulated nicotine and device results in a product that provides higher doses of nicotine than cigarette products, delivering almost no throat irritation while delivering increased doses of nicotine.”

It also claims that JUUL and associated tobacco companies “failed to disclose to consumers the JUUL products deliver an exceptionally potent dose of nicotine” and “fraudulently concealed material information about the addictive nature of its e-cigarettes.”

The lawsuit requests an unidentified amount of compensatory and punitive damages.

A JUUL spokesperson sent the following statement Wednesday afternoon:

On nicotine content: “We selected the 5% nicotine concentration in our products to provide adult smokers with a viable, satisfying alternative to combustible cigarettes. Our clinical studies have consistently shown that 5% strength JUUL pod use results in a nicotine uptake similar to, but lower than, a cigarette. We specifically designed for this familiar nicotine experience in order to satisfy adult smokers and help them transition from combustible use and, ultimately, eliminate cigarette consumption. We also offer 3% strength products so that adult smokers have the option to choose different nicotine strengths and help them customize their switching journey.” 

The lawsuit, and more than 110 similar active complaints nationwide, comes as health leaders report a growing number of deaths and illnesses associated with e-cigarette use.

Those at the Centers for Disease Control (CDC) have yet to pinpoint what specific product or substance is linked to all the cases. In the meantime, those at the CDC recommend consumers consider refraining from using vaping products, particularly those with THC.

©TEGNA Inc. 2019. All Rights Reserved.

What's Trending Now

Don't Miss

More Don't Miss

Event Calendar